Inactive Instrument
Cyclopharm Limited Stock OTC Markets
Stocks
CYCM.F
AU000000CYC5
Advanced Medical Equipment & Technology
OTC Markets Traded| Market Cap | 73.75M 51.77M 45M 41.89M 38.46M 72.62M 4.94B 494M 194M 2.46B 194M 190M 8.25B | P/E 2026 * |
-3.95x | P/E 2027 * | -8.46x |
|---|---|---|---|---|---|
| Enterprise Value | 73.75M 51.77M 45M 41.89M 38.46M 72.62M 4.94B 494M 194M 2.46B 194M 190M 8.25B | EV / Sales 2026 * |
2.01x | EV / Sales 2027 * | 1.6x |
| Free-Float |
58.05% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Cyclopharm Limited
| Manager | Title | Age | Since |
|---|---|---|---|
James McBrayer
CEO | Chief Executive Officer | 60 | 2009-10-20 |
Jason Smith
DFI | Director of Finance/CFO | - | 2024-02-25 |
Mathew Farag
COO | Chief Operating Officer | - | 2016-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
James McBrayer
BRD | Director/Board Member | 60 | 2008-06-02 |
Dianne Angus
BRD | Director/Board Member | 65 | 2021-08-09 |
Kevin Barrow
BRD | Director/Board Member | - | 2022-08-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 51.77M | ||
| -0.43% | +1.06% | +24.03% | +3.71% | 212B | ||
| -0.61% | +1.82% | -1.07% | -24.39% | 137B | ||
| +0.10% | +4.69% | -26.86% | +12.57% | 125B | ||
| +1.59% | +5.60% | -55.67% | -7.68% | 69.46B | ||
| -0.98% | +4.16% | +8.50% | +7.08% | 49.56B | ||
| -0.91% | +5.13% | -20.61% | -25.35% | 47.2B | ||
| -0.25% | -0.14% | +21.91% | +8.35% | 39.08B | ||
| -0.79% | +0.70% | +29.97% | +29.32% | 37.05B | ||
| +0.00% | +5.67% | +116.67% | +8.20% | 30.97B | ||
| Average | -0.23% | +3.19% | +10.76% | +1.31% | 83.06B | |
| Weighted average by Cap. | -0.24% | +2.80% | +3.70% | -0.94% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 36.6M 25.69M 22.33M 20.79M 19.09M 36.04M 2.45B 245M 96.17M 1.22B 96.49M 94.37M 4.09B | 46.2M 32.43M 28.19M 26.24M 24.09M 45.5M 3.1B 309M 121M 1.54B 122M 119M 5.17B |
| Net income | -18.9M -13.27M -11.53M -10.73M -9.86M -18.61M -1.27B -127M -49.66M -631M -49.83M -48.73M -2.11B | -9.9M -6.95M -6.04M -5.62M -5.16M -9.75M -663M -66.28M -26.01M -330M -26.1M -25.53M -1.11B |
| Net Debt | - | - |
Employees
109

















